Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Methylselenocysteine preventing castration-resistant progression of prostate cancer.

Liu Y, Liu X, Guo Y, Liang Z, Tian Y, Lu L, Zhao X, Sun Y, Zhao X, Zhang H, Dong Y.

Prostate. 2015 Jun 15;75(9):1001-8. doi: 10.1002/pros.22987.

2.

The interaction between epigenetics, nutrition and the development of cancer.

Bishop KS, Ferguson LR.

Nutrients. 2015 Jan 30;7(2):922-47. doi: 10.3390/nu7020922. Review.

3.

Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancer.

Zhan Y, Cao B, Qi Y, Liu S, Zhang Q, Zhou W, Xu D, Lu H, Sartor O, Kong W, Zhang H, Dong Y.

Int J Cancer. 2013 Nov;133(9):2225-33. doi: 10.1002/ijc.28202.

4.

Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.

Christensen MJ, Quiner TE, Nakken HL, Lephart ED, Eggett DL, Urie PM.

Prostate. 2013 Jun;73(9):986-95. doi: 10.1002/pros.22646.

5.

Pharmacokinetics and cytotoxic effect of selenium compounds in rodent cancer xenograft model for therapy experiment.

Hwang JY.

J Gynecol Oncol. 2013 Jan;24(1):96-7. doi: 10.3802/jgo.2013.24.1.96. No abstract available.

6.

Soy content of basal diets determines the effects of supplemental selenium in male mice.

Quiner TE, Nakken HL, Mason BA, Lephart ED, Hancock CR, Christensen MJ.

J Nutr. 2011 Dec;141(12):2159-65. doi: 10.3945/jn.111.146498.

7.

Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.

Ledesma MC, Jung-Hynes B, Schmit TL, Kumar R, Mukhtar H, Ahmad N.

Mol Med. 2011 Jan-Feb;17(1-2):134-43. doi: 10.2119/molmed.2010.00136. Review.

8.

1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.

Facompre ND, El-Bayoumy K, Sun YW, Pinto JT, Sinha R.

Cancer Prev Res (Phila). 2010 Aug;3(8):975-84. doi: 10.1158/1940-6207.CAPR-10-0054.

9.

Telomerase as an important target of androgen signaling blockade for prostate cancer treatment.

Liu S, Qi Y, Ge Y, Duplessis T, Rowan BG, Ip C, Cheng H, Rennie PS, Horikawa I, Lustig AJ, Yu Q, Zhang H, Dong Y.

Mol Cancer Ther. 2010 Jul;9(7):2016-25. doi: 10.1158/1535-7163.MCT-09-0924.

10.

Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.

Lindshield BL, Ford NA, Canene-Adams K, Diamond AM, Wallig MA, Erdman JW Jr.

PLoS One. 2010 Apr 29;5(4):e10423. doi: 10.1371/journal.pone.0010423.

11.

Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells.

Abdulah R, Faried A, Kobayashi K, Yamazaki C, Suradji EW, Ito K, Suzuki K, Murakami M, Kuwano H, Koyama H.

BMC Cancer. 2009 Nov 30;9:414. doi: 10.1186/1471-2407-9-414.

12.

Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells.

Lee JI, Nian H, Cooper AJ, Sinha R, Dai J, Bisson WH, Dashwood RH, Pinto JT.

Cancer Prev Res (Phila). 2009 Jul;2(7):683-93. doi: 10.1158/1940-6207.CAPR-09-0047.

13.

Diets high in selenium and isoflavones decrease androgen-regulated gene expression in healthy rat dorsolateral prostate.

Legg RL, Tolman JR, Lovinger CT, Lephart ED, Setchell KD, Christensen MJ.

Reprod Biol Endocrinol. 2008 Nov 24;6:57. doi: 10.1186/1477-7827-6-57.

14.

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

Li GX, Lee HJ, Wang Z, Hu H, Liao JD, Watts JC, Combs GF Jr, Lü J.

Carcinogenesis. 2008 May;29(5):1005-12. doi: 10.1093/carcin/bgn007.

15.

Selenium-Binding Protein 1 expression in ovaries and ovarian tumors in the laying hen, a spontaneous model of human ovarian cancer.

Stammer K, Edassery SL, Barua A, Bitterman P, Bahr JM, Hales DB, Luborsky JL.

Gynecol Oncol. 2008 Apr;109(1):115-21. doi: 10.1016/j.ygyno.2007.12.030.

16.

Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter.

Chun JY, Hu Y, Pinder E, Wu J, Li F, Gao AC.

Mol Cancer Ther. 2007 Sep;6(9):2572-80.

17.
Items per page

Supplemental Content

Support Center